The current EoE therapy is based on food elimination; anti-inflammatory treatments restricted to the use of glucocorticoids and humanized anti-IL-5 antibody treatment.31, 58 The anti-IL-5 antibody therapy is promising but their preliminary results in clinical trials are not as encouraging as hoped. Here, IL5 is linked to eosinophilic esophagitis.